Brazil
About Dako
When a person is confronted with a possible cancer diagnosis, a biopsy is performed and tissue is taken out. The tissue is tested in a pathology lab and a report is generated. The report confirms or rules out a cancer diagnosis and determines the ‘stages’ or to what extent the cancer has spread. Treatment options are found by information on the size, shape and appearance of the tissue under a microscope. Dako provides the antibodies; reagents and instruments enabling physicians choose the right form of treatment, the first time.
We are helping doctors help their patients.
News
Dako to Offer New Antibody in U.S. to Diagnose Breast Cancer
Apr 03, 2013
-
FDA Approves Dako Assays as CDx for Genentech’s New Breast Cancer Medicine Kadcyla
Mar 05, 2013
-
Dako Launches Advanced Staining Platform
Mar 04, 2013
-
Dako Receives FDA Approval for Fast, Accurate, Nontoxic FISH Assay for Cancer Diagnostics
Feb 15, 2013
Press Information
Legal Information
Annual Report 2011
It's all about cancer!
We fight cancer by providing high quality antibodies, instruments and software. We are raising the global standards for fast and accurate diagnostic answers for cancer patients.